Skip to main content
Equibles
DOCS logo

DOCS · Doximity, Inc. · Metrics

Track DOCS — free

Use DOCS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DOCS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$26.35 +0.77 (+3.01%) At close · Sep 14
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$4.70B
Shares
178.25M

DOCS metrics

77 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$25.58
Market cap
$4.70B

Price action

20 metrics
Price change (1W)
-2.9%
Price change (30D)
+4.3%
Price change (3M)
+27.6%
Price change (6M)
+5.0%
Price change (YTD)
-42.2%
Price change (1Y)
-63.6%
Trailing year
Price change (5Y)
-74.9%
52-week high
$75.12
52-week low
$18.01
Change from 52-week high
-65.9%
Change from 52-week low
+42.0%
Annualized volatility
63.8%
Annualized volatility (3M)
80.3%
Beta
0.7
RSI (14D)
53.6
Price vs SMA 50
+8.4%
Price vs SMA 200
-9.9%
Avg volume (3M)
4.62M
Relative volume
0.6
Average dollar volume
$109.68M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
178.25M

Valuation

12 metrics
P / E (TTM)
30.5
Trailing earnings · reciprocal yield 3.3%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
7.0×
reciprocal yield 14.4%
P / book
5.0
reciprocal yield 20.1%
FCF yield
—
TTM · current market cap
Buyback yield
8.8%
P / FCF
—
P / operating cash flow
14.9
reciprocal yield 6.7%
Earnings yield
3.7%

Historical valuation

8 metrics
P / E historical average (3Y)
41.0×
reciprocal yield 2.4%
P / E historical average (5Y)
44.0×
reciprocal yield 2.3%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
8.8%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
88.1%
Operating margin
29.6%
Trailing 12 months
Net margin
25.5%
Gross profit (TTM)
$577.34M
Operating profit (TTM)
$194.05M
Net income (TTM)
$167.05M
Trailing 12 months
Diluted EPS (TTM)
$0.84
FCF margin
—
Effective tax rate
26.2%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$5.09

Growth

11 metrics
Revenue growth YoY
+7.3%
Year over year
Net income growth YoY
-54.4%
Revenue (TTM)
$655.57M
Trailing 12 months
EPS growth YoY
-51.9%
Shares change YoY
-5.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+15.5%
Revenue CAGR (5Y)
+25.5%
EPS CAGR (3Y)
+22.7%
EPS CAGR (5Y)
+33.6%
FCF CAGR (3Y)
+22.4%
FCF CAGR (5Y)
+31.6%

Quality

14 metrics
Return on equity
18.2%
Return on assets
15.4%
Debt / equity
—
Current ratio
6.1
EBITDA (TTM)
$209.92M
Free cash flow (TTM)
—
Quick ratio
6.1
Interest coverage
—
Net debt / EBITDA
-1.3
Return on invested capital
—
Trailing 12 months
Net cash
$273.60M
Latest balance sheet
Cash & equivalents
$273.60M
Total assets
$1.08B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$306.34M
Capital expenditures (TTM)
$62,000
R&D (TTM)
$142.38M
SG&A (TTM)
—
Stock compensation (TTM)
$136.51M
R&D / revenue
21.7%
Stock compensation / revenue
20.8%

Ownership (13F)

3 metrics
13F filers
361
13F filer change QoQ
-69
Institutional ownership
73.1%

Short interest

3 metrics
Short interest
7.9%
Latest settlement · 5.0 days to cover
Days to cover
5.0d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$478,167
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1516513 CUSIP 26622P107 13F (30d) 21 filings 19 filers Visit website Investor relations